During the early phases of cancer, activated immune cells (NKs, CD8+, CD4+ T cells) secrete IFNγ, thereby modulating the activity of macrophages, DCs, Th1 CD4+helper T cells, and B cells to eliminate cancer cells. This evidence concerns the gene CD8A and cancer.